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CASE REPORT
CK20 Positive Large-cell Neuroendocrine Carcinoma 
Presenting with Skin Metastases
Min-Kyung Shin, M.D., Chang-Min Choi, M.D., Yu-Jin Oh, M.D., Nack-In Kim, M.D.
Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea
We present a case of cytokeratin (CK) 20-positive large cell 
neuroendocrine carcinoma (LCNEC) presenting with multiple 
skin metastases as the primary manifestation. The patient was 
a 55-year-old man who presented with a one- month history of 
subcutaneous skin colored nodules of various sizes on his 
trunk. Pathologic examination of the skin revealed a nested 
and solid proliferation of large undifferentiated cells with 
vesicular nuclei and prominent nucleoli. Tumor cells were 
found to be immunohistochemically positive for CK 20, 
chromogranin A, synaptophysin, and CD56. Based on these 
features, the tumor was diagnosed as a large cell 
neuroendocrine carcinoma with multiple skin metastases. 
Computed tomographic (CT) imaging found metastatic foci in 
the liver, pleura, bone, and lymph nodes. We were unable to 
identify the primary site of origin. To the best of our knowledge, 
this is the first case of a large cell neuroendocrine carcinoma 
with a primary manifestation of multiple skin metastases. (Ann 
Dermatol 23(S1) S20∼S24, 2011)
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INTRODUCTION
Neuroendocrine tumors (NET) are characterized by fea-
tures of both neuroendocrine and epithelial differentiation 
based on immunohistochemical and biochemical exami-
nations. Specific types of NETs include small cell carcino-
ma (SCC), typical and atypical carcinoid tumors, and large 
cell neuroendocrine carcinoma (LCNEC).
LCNEC of the lungs was first described by Travis et al.
1 
LCNEC presents with typical features of NET, including 
organoid nesting, palisading, rosettes, trabecular patterns, 
high mitotic rate, and positivity for neuroendocrine 
markers based on immunohistochemistry. Occurrence of 
LCNEC is rare; however, the histological and 
immunohistochemical profile, as well as the prognosis for 
these tumors, are not well defined.
In a study of metastatic skin tumors, Chu and associates
2 
showed cytokeratin (CK) 20 positivity in almost all colo-
rectal carcinomas and Merkel cell tumors, pancreatic carci-
nomas (62%), gastric carcinomas (50%), cholangiocarcinomas 
(43%), and transitional cell carcinomas (29%), and was 
nearly absent in carcinomas from other organ systems. 
However, in our case, LCNEC was found to be immuno-
histochemically positive for CK20, regardless of the original 
primary site. Expression of CK20 may not be useful in 
determining the site of origin for patients with LCNEC. 
CASE REPORT
A 55-year-old man presented with a one-month history of 
skin lesions on his trunk. The lesions were well-circum-
scribed, skin-colored, asymptomatic subcutaneous nodu-
les measuring 1∼2 cm (Fig. 1). Several new lesions had 
developed on the head, neck, and leg within the past 10 
days. Tumor marker values revealed an increase in serum 
carcinoembryonic antigen (CEA) (CEA; 513 ng/ml, normal 
range ＜4.1 ng/ml), carbohydrate antigen (CA) 19-9 (CA 
19-9; 8,457 ng/ml, normal range ＜37 U/ml), and alpha 
fetoprotein (aFP; 37.13 ng/ml, normal range ＜4.0 ng/ml).
The patient had been a chronic hepatitis B virus (HBV)  CK20 Positive Large-cell Neuroendocrine Carcinoma Presenting with Skin Metastases
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Fig. 2. Microscopic findings of a large cell neuroendocrine carcinoma. (A) Low-power view showing sheets of tumor cells with a
trabecular or organoid growth pattern in the subcutaneous area. (B) High-power view showing large pleomorphic cells with 
hyperchromatic nuclei, coarse chromatin, and numerous mitotic figures (H&E, A: ×40, B: ×200, respectively).
Fig. 1. Skin examination revealed multiple well-demarcated, 
skin-colored subcutaneous nodules on the trunk.
carrier for the previous five years. However, previous liver 
enzyme levels and abdominal computed tomographic (CT) 
images were unremarkable. Histopathologic examination of 
a subcutaneous nodule on the trunk showed cohesive 
sheets of cells with a prominent trabecular or organoid 
arrangement. The tumor was primarily located in the sub-
cutaneous fat layer without connections to the epidermis 
and dermis. It showed nests composed of pleomorphic 
cells with surrounding lymphoid stroma (Fig. 2). Tumor 
cells were pleomorphic and larger than those seen in 
conventional Merkel cell carcinoma. Nuclei of tumor cells 
were hyperchromatic and vesicular with prominent 
nucleoli (Fig. 2). Mitotic figures were prominent. Cells 
showed positive immunoreactivity for CD56, chromo-
granin, and synaptophysin. CK20 expression was diffuse 
in the cytoplasm; however, no dot-like perinuclear posi-
tivity was observed (Fig. 3). Tumor cells showed negative 
immunoreactivity for HMB45, S-100, CK7, LCA, and 
TTF-1 (Thyroid transcription factor-1), vimentin, and neuro-
filament. 
CT imaging showed enhanced masses on the liver, pleura, 
bone, and lymph nodes. The colon and rectum were 
found to be intact by colonoscopy. However, we were not 
able to identify the primary site of the malignancy. Dia-
gnosis of a large cell neuroendocrine carcinoma with 
multiple skin metastases was established, and the patient 
received chemotherapy based on cisplatin and etoposide. 
Two months after appearance of cutaneous lesions, the 
patient died from septic shock. 
DISCUSSION
LCNEC is characterized by (I) neuroendocrine appearance 
on a light microscope, (II) large cell size (up to three times 
larger than normal lymphocytes), polygonal shape, low 
nuclear-cytoplasmic ratio, coarse nuclear chromatin and 
frequent nucleoli, (III) high mitotic rate (＞10/10 high- 
power fields (HPF)) and frequent necrosis, and (IV) neur-
oendocrine features detected by immunohistochemistry or 
electron microscopy
1.
LCNEC has recently been reported in various organs, in-
cluding the lungs
3, breasts
4, uterine cervix
5, gallbladder
6, 
urinary bladder
7, ovaries
8, and colon
9. Distant metastases 
from a primary visceral LCNEC tumor are not unusual. MK Shin, et al
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Fig. 3. (A) Immunohistochemical staining for CD56 showed positivity for tumor cells in a cytoplasmic pattern. (B, C) Tumor cells
were focally positive for chromogranin and synaptophysin. (D) CK20, showing diffuse cytoplasmic staining of tumor cells (Immuno-
peroxidase, ×100).
Liver and bone were the most common sites of metas-
tases
4. Cutaneous metastasis from neuroendocrine carcino-
mas of visceral origin has rarely been described. Only two 
cases of LCNEC presenting with skin metastasis have been 
reported in the literature
10,11. The primary sites of origin 
were the urinary bladder and rectum, and both tumors 
appeared as a single lesion on the scalp. In fact, no cases of 
multiple cutaneous metastasis, such as this case in LCNEC, 
have been reported. In particular, a case of cutaneous 
metastasis originating from the urinary bladder showed 
extremely poor prognosis, and, like this case, the patient 
died after two months due to cutaneous metastasis
9.
The distribution of CK20, a 46 kDa basic protein, is almost 
entirely confined to the gastrointestinal epithelium, uro-
thelium, and Merkel cells
6. Colorectal adenocarcinomas 
strongly express CK20 in more than half of the tumor 
cells
2,12. Due to unremarkable findings on colonoscopy, 
we excluded the colon as the primary site of malignancy. 
Thyroid transcription factor-1 (TTF-1) is a 38 kDa trans-
cription factor expressed in the thyroid, lungs, urinary 
bladder, and certain areas of the brain
10,13. In this case, a 
stain for TTF-1 was negative and there was no evidence of 
invasion into the urinary tract. Cutaneous metastatic NEC 
must be differentiated from Merkel cell carcinoma. In 
addition, its in differentiation between LCNEC and Mer-
kel cell carcinoma when predicting the prognosis of a 
patient. LCNEC is distinguished from Merkel cell carci-
noma by the presence of larger and more pleomorphic 
cells, which have prominent nucleoli and lack dot-like 
positive staining for CK20. In this case, cytoplasmic stai-
ning for CK20 was found, and cells seemed larger and 
more pleomorphic, this case was considered as LCNEC.
Clinically, cutaneous involvement of Merkel cell carci-
noma is seen primarily in areas of the skin that have high 
sun exposure, including the head, neck, and extremities. 
Less than ten percent of cases of Merkel cell carcinoma 
are reported on the trunk. Most patients with Merkel cell 
carcinoma are in their seventh decade or older. Only five CK20 Positive Large-cell Neuroendocrine Carcinoma Presenting with Skin Metastases
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Table 1. Reported cases of CK20-positive LCNEC in the inter-
national literature
Authors Age/Sex Pattern* Primary 
site
Site of 
metastases 
Kato et al.
17 69/F Membranous Colon Liver
Lee et al.
11 58/M N/A
† Rectum Skin
Dundr et al.
18 73/F N/A Ovary Brain
Kasami et al.
19 63/F Membranous Skin No
95/M N/A Skin No
Lee et al.
10 20/M Cytoplasmic Urinary Skin
 bladder
Okoshi et al.
4 63/F N/A Breast No
Present case 55/M Cytoplasmic Unknown Bone,
 liver,
 skin
*Pattern: membranous or cytoplasmic, 
†N/A: not applicable.
percent are below the age of 50 at the time of diagnosis
14. 
In the present case, based on histopathology, the tumor 
mass was limited to the subcutis. Tumors were first seen 
on the trunk in a relatively young patient and the pro-
gression was very rapid. Due to the sudden onset and 
appearance of multiple subcutaneous lesions, we were 
strongly suspicious of metastatic carcinoma from other 
visceral organs. Therefore, we presumed that the lesions 
were cutaneous metastases from visceral LCNEC. 
Nassar et al.
15 reported that CK20 expression was seen in 
one third of the high grade neuroendocrine carcinomas of 
the ampulla of Vater; however, it was not in any small cell 
carcinomas. Adegbola et al.
16 reported that small cell NEC of 
the breast showed focal positivity for CK7 and was negative 
for CK20. Seven cases of CK20 positive LCNEC have been 
reported
4,10,11,17-19. Primary sites of origin included the colon, 
rectum, ovaries, skin, urinary bladder, and breasts (Table 1). 
CK20 shows a membranous or cytoplasmic staining pattern 
with focal or diffuse positivity. Four cases showed a weak 
and focal pattern and one case showed a diffuse pattern 
similar to that of the present case. Therefore, positivity for 
CK20 is thought to be seen in LCNEC. Further studies are 
necessary in order to understand the implications of CK20 
positivity in patients who have LCNEC.
We have described the first case of multiple cutaneous 
metastases from an LCNEC of unknown origin. LCNEC is 
very rare, and its biological behavior and immunohisto-
chemistry have not been well documented.
Distinguishing between Merkel cell carcinoma and 
LCNEC showing positive staining for CK20 on the skin 
lesion is necessary.
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